Downregulation Of Ggpps In Chondrocytes Accelerates Osteoarthritis Progression

Chao Wang,Si-Cong Min,Ke-Lu,Hao-Jun Zhang,Jing Wu,Yu-Bao Liu,Ping Mao,Chao-Jun Li,Qing Jiang
2017-01-01
Abstract:Geranylgeranyl pyrophosphate synthase (GGPPS) is a key protein in the mevalonate metabolic pathway, catalyzing the synthesis of geranylgeranyl pyrophosphate (GGPP), which is essential for protein geranylgeranylation. The mevalonate pathway has been reported to participate in the regulation of articular cartilage homeostasis. The role of statins in treating osteoarthritis remains unclear and controversial. Meanwhile, the adverse effects of statins, due to their total inhibition of protein prenylation, are increasingly recognized. We investigated the role of GGPPS in the development of osteoarthritis (OA). We observed downregulated GGPPS protein levels in both mice OA cartilage and human OA samples. GGPPS was deleted from the articular chondrocytes of 2-week-old mice in a cartilage specific and tamoxifen-inducible manner. GGPPS deficiency aggravated the development of cartilage destruction after surgically induced destabilization of the knee joint, at both 8 and 10 weeks after surgery. In another ageing animal model, the articular cartilage of GGPPS cKO mice exhibited more proteoglycan loss than WT mice at both 4 and 10 months old. We also observed that disruption of GGPPS led to elevated chondrocyte apoptosis at an early stage. Relative to their normal cartilage counterparts, in vitro mRNA levels of ADAMTS5 and MMP-13 were increased 231% and 228%, respectively, in the absence of GGPPS. This correlation between GGPPS expression level and OA progression suggests that GGPPS plays a critical role in maintaining cartilage homeostasis.
What problem does this paper attempt to address?